Filing Details
- Accession Number:
- 0001213809-19-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-11 16:17:25
- Reporting Period:
- 2019-10-10
- Accepted Time:
- 2019-10-11 16:17:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1213809 | Dyadic International Inc | DYAI | Biological Products, (No Disgnostic Substances) (2836) | 450486747 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761230 | Ronen Tchelet | 140 Intracoastal Pointe Drive Suite 404 Jupiter FL 33477-5094 | Vp Of Research And Bus. Dvlpmt | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-10 | 4,782 | $1.41 | 4,782 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-10-10 | 4,782 | $6.04 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-10-11 | 5,218 | $1.41 | 5,218 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-10-11 | 5,218 | $6.08 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2019-10-10 | 4,782 | $0.00 | 4,782 | $1.41 |
| Common Stock | Stock Option | Disposition | 2019-10-11 | 5,218 | $0.00 | 5,218 | $1.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,218 | 2015-12-31 | 2024-04-30 | No | 4 | M | Direct |
| 20,000 | 2015-12-31 | 2024-04-30 | No | 4 | M | Direct |
Footnotes
- The sale of the shares of Class A Common Stock were made pursuant to Rule 10b5-1 trading plan adopted on June 11, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.25, inclusive. The reporting person undertakes to provide to Dyadic International, Inc., any security holder of Dyadic International, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.24, inclusive. The reporting person undertakes to provide to Dyadic International, Inc., any security holder of Dyadic International, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of footnote (1) to this Form 4.
Billionaire Hedge Funds
